Literature DB >> 7525076

The implications of angiogenesis for the biology and therapy of cancer metastasis.

I J Fidler1, L M Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7525076     DOI： 10.1016/0092-8674(94)90187-2

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  221 in total

1.  Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.

Authors:  J A Beliën; S Somi; J S de Jong; P J van Diest; J P Baak
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer.

Authors:  Nicole D Fleming; Robert L Coleman; Celestine Tung; Shannon N Westin; Wei Hu; Yunjie Sun; Priya Bhosale; Mark F Munsell; Anil K Sood
Journal:  Gynecol Oncol       Date:  2017-08-01       Impact factor: 5.482

3.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

Authors:  C J Bruns; M T Harbison; H Kuniyasu; I Eue; I J Fidler
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

4.  Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.

Authors:  Gerald S Falchook; Jennifer J Wheler; Aung Naing; Sarina A Piha-Paul; Siqing Fu; Apostolia M Tsimberidou; David S Hong; Filip Janku; Ralph Zinner; Yunfang Jiang; Mei Huang; Quan Lin; Kristin Parkhurst; Razelle Kurzrock
Journal:  Invest New Drugs       Date:  2014-11-04       Impact factor: 3.850

5.  HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.

Authors:  E Laughner; P Taghavi; K Chiles; P C Mahon; G L Semenza
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.

Authors:  M Watanabe; K L McCormick; K Volker; J R Ortaldo; J M Wigginton; M J Brunda; R H Wiltrout; W E Fogler
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

7.  Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro.

Authors:  A Papapetropoulos; K M Desai; R D Rudic; B Mayer; R Zhang; M P Ruiz-Torres; G García-Cardeña; J A Madri; W C Sessa
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 8.  Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.

Authors:  Mian M K Shahzad; Yong-Hyun Shin; Koji Matsuo; Chunhua Lu; Masato Nishimura; De-Yo Shen; Yu Kang; Wei Hu; Edna M Mora; Cristian Rodriguez-Aguayo; Arvinder Kapur; Justin Bottsford-Miller; Gabriel Lopez-Berestein; Aleksandar Rajkovic; Anil K Sood
Journal:  Cancer Lett       Date:  2012-07-07       Impact factor: 8.679

9.  Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.

Authors:  C J Dimitroff; W Klohs; A Sharma; P Pera; D Driscoll; J Veith; R Steinkampf; M Schroeder; S Klutchko; A Sumlin; B Henderson; T J Dougherty; R J Bernacki
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

10.  Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.

Authors:  Sho-ichi Yamagishi; Riichiro Abe; Yosuke Inagaki; Kazuo Nakamura; Hiroshi Sugawara; Daisuke Inokuma; Hideki Nakamura; Tadamichi Shimizu; Masayoshi Takeuchi; Akihiko Yoshimura; Richard Bucala; Hiroshi Shimizu; Tsutomu Imaizumi
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.